Immune-relevant aspects of murine models of head and neck cancer.
Journal
Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
28
09
2018
accepted:
05
12
2018
revised:
26
11
2018
pubmed:
31
1
2019
medline:
12
10
2019
entrez:
31
1
2019
Statut:
ppublish
Résumé
Head and neck cancers (HNCs) cause significant mortality and morbidity. There have been few advances in therapeutic management of HNC in the past 4 to 5 decades, which support the need for studies focusing on HNC biology. In recent years, increased recognition of the relevance of the host response in cancer progression has led to novel therapeutic strategies and putative biomarkers of tumor aggressiveness. However, tumor-immune interactions are highly complex and vary with cancer type. Pre-clinical, in vivo models represent an important and necessary step in understanding biological processes involved in development, progression and treatment of HNC. Rodents (mice, rats, hamsters) are the most frequently used animal models in HNC research. The relevance and utility of information generated by studies in murine models is unquestionable, but it is also limited in application to tumor-immune interactions. In this review, we present information regarding the immune-specific characteristics of the murine models most commonly used in HNC research, including immunocompromised and immunocompetent animals. The particular characteristics of xenograft, chemically induced, syngeneic, transgenic, and humanized models are discussed in order to provide context and insight for researchers interested in the in vivo study of tumor-immune interactions in HNC.
Identifiants
pubmed: 30696955
doi: 10.1038/s41388-019-0686-9
pii: 10.1038/s41388-019-0686-9
pmc: PMC6533118
mid: NIHMS1516139
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3973-3988Subventions
Organisme : NIDCR NIH HHS
ID : R01 DE022567
Pays : United States
Organisme : NIDCR NIH HHS
ID : R35 DE027551
Pays : United States
Références
Oral Oncol. 2006 May;42(5):448-60
pubmed: 16266822
Cancer Genomics Proteomics. 2012 Sep-Oct;9(5):329-35
pubmed: 22990112
Annu Rev Biochem. 2010;79:181-211
pubmed: 20192759
Cell. 1993 Apr 9;73(1):147-57
pubmed: 8462096
Oncogene. 2016 Jan 21;35(3):290-300
pubmed: 25893296
Otolaryngol Head Neck Surg. 2006 Dec;135(6):853-7
pubmed: 17141073
FASEB J. 2011 Jul;25(7):2387-98
pubmed: 21471252
PLoS One. 2010 Jan 25;5(1):e8870
pubmed: 20111598
Biomed Pharmacother. 2018 Feb;98:484-490
pubmed: 29287195
Int J Cancer. 2006 May 1;118(9):2111-22
pubmed: 16380986
J Clin Invest. 2009 Nov;119(11):3408-19
pubmed: 19841536
J Immunol. 1993 May 1;150(9):3817-24
pubmed: 8473734
J Oral Pathol Med. 1995 Jan;24(1):23-31
pubmed: 7536846
Physiol Res. 2016 Dec 21;65(Suppl 4):S441-S453
pubmed: 28006926
Cancer Res. 2004 Jan 15;64(2):452-5
pubmed: 14744755
Laryngoscope. 1995 Oct;105(10):1077-80
pubmed: 7564839
Oral Dis. 2003 Nov;9(6):305-12
pubmed: 14629332
Cell Res. 2017 Jul;27(7):916-932
pubmed: 28374746
Arthritis Rheum. 2013 Apr;65(4):949-59
pubmed: 23280308
Br J Cancer. 1971 Sep;25(3):533-7
pubmed: 5144526
Nat Commun. 2017 Oct 3;8(1):766
pubmed: 28974683
J Dent Res. 1954 Apr;33(2):253-62
pubmed: 13152263
Oncotarget. 2017 Jan 10;8(2):2053-2068
pubmed: 28008146
Cancer Res. 2009 Jul 15;69(14):5918-26
pubmed: 19584284
Curr Opin Support Palliat Care. 2018 Mar;12(1):65-73
pubmed: 29232259
Hum Immunol. 2009 Oct;70(10):790-802
pubmed: 19524633
Nat Biotechnol. 2014 Apr;32(4):364-72
pubmed: 24633240
Cancer Res. 1994 Oct 15;54(20):5310-7
pubmed: 7923158
Cancer Immunol Res. 2016 Dec;4(12):1061-1071
pubmed: 27821498
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Mol Carcinog. 2009 Sep;48(9):853-61
pubmed: 19263437
Immunity. 2007 May;26(5):537-41
pubmed: 17521579
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10285-90
pubmed: 8816792
Cancer Metastasis Rev. 2005 Jan;24(1):107-27
pubmed: 15785876
Cancer Res. 1992 Jan 15;52(2):389-93
pubmed: 1728410
Cell Physiol Biochem. 2017;43(6):2379-2390
pubmed: 29073625
Nature. 1964 Jul 4;203:90-2
pubmed: 14197363
Nat Rev Immunol. 2007 Feb;7(2):118-30
pubmed: 17259968
Inflamm Res. 2011 Feb;60(2):195-201
pubmed: 20924638
Cancer Immunol Res. 2017 Mar;5(3):234-247
pubmed: 28159748
J Infect Dis. 1995 Oct;172(4):974-82
pubmed: 7561218
Methods Achiev Exp Pathol. 1975;7:149-66
pubmed: 1105061
Head Neck. 2006 Oct;28(10):945-54
pubmed: 16721744
Cancer Immunol Res. 2018 Jul;6(7):788-797
pubmed: 29764837
Mol Cancer Res. 2017 Sep;15(9):1138-1152
pubmed: 28512253
Blood. 1996 Feb 1;87(3):956-67
pubmed: 8562967
Bone Marrow Transplant. 2000 Dec;26(11):1211-6
pubmed: 11149733
Int J Oral Sci. 2011 Oct;3(4):180-91
pubmed: 22010576
Lab Anim. 1990 Jul;24(3):228-33
pubmed: 2395321
Mol Cell Biochem. 2018 Mar;440(1-2):11-22
pubmed: 28801714
J Exp Clin Cancer Res. 2018 Mar 5;37(1):44
pubmed: 29506555
Clin Cancer Res. 2000 Jul;6(7):2794-802
pubmed: 10914726
Oncogene. 2017 Feb 2;36(5):687-699
pubmed: 27375020
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8551-6
pubmed: 10411913
APMIS Suppl. 1991;21:1-39
pubmed: 2043379
J Clin Invest. 2002 Sep;110(6):761-9
pubmed: 12235107
Vet Pathol. 2012 Jan;49(1):32-43
pubmed: 22135019
J Oral Pathol. 1981 Oct;10(5):322-31
pubmed: 6801230
J Leukoc Biol. 1984 Jun;35(6):605-15
pubmed: 6586943
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
Iran J Basic Med Sci. 2014 May;17(5):391-5
pubmed: 24967069
Blood. 2005 Sep 1;106(5):1565-73
pubmed: 15920010
Int J Oral Maxillofac Surg. 1995 Feb;24(1 Pt 1):53-8
pubmed: 7782642
Cancer Res. 2012 Jan 1;72(1):365-74
pubmed: 22086849
Mol Cancer Res. 2006 Jun;4(6):401-10
pubmed: 16778087
J Exp Med. 1993 Dec 1;178(6):1981-94
pubmed: 8245777
J Infect Dis. 2009 Mar 1;199(5):673-9
pubmed: 19199545
J Pathol. 2016 Oct;240(2):224-34
pubmed: 27447534
Dig Dis Sci. 2015 Aug;60(8):2251-63
pubmed: 25840920
Blood. 2002 Nov 1;100(9):3175-82
pubmed: 12384415
Arch Otolaryngol Head Neck Surg. 1997 Jan;123(1):20-4
pubmed: 9006499
Oral Oncol. 2013 Apr;49(4):299-305
pubmed: 23187306
Immunol Rev. 2013 Mar;252(1):116-32
pubmed: 23405899
J Oral Pathol. 1985 Mar;14(3):263-7
pubmed: 3921682
Stem Cell Reports. 2015 Feb 10;4(2):171-80
pubmed: 25601207
Blood. 2013 Oct 31;122(18):3160-4
pubmed: 23980063
Hematol Oncol Clin North Am. 2006 Jun;20(3):585-612
pubmed: 16762726
Genes Dev. 2006 May 15;20(10):1331-42
pubmed: 16702406
Cancer. 2003 Mar 15;97(6):1464-70
pubmed: 12627511
Radiat Res. 2004 Feb;161(2):143-52
pubmed: 14731076
Cancer Lett. 2016 Oct 10;381(1):156-64
pubmed: 27431309
Oral Oncol. 2017 Oct;73:16-20
pubmed: 28939069
Anticancer Res. 2003 Mar-Apr;23(2B):1467-71
pubmed: 12820411
Oral Oncol. 2002 Jun;38(4):349-56
pubmed: 12076698
Cell. 1992 Mar 6;68(5):869-77
pubmed: 1547488
Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1473-8
pubmed: 6206039
PLoS One. 2011;6(11):e27508
pubmed: 22096586
J Clin Oncol. 2017 Nov 1;35(31):3601-3609
pubmed: 28880746
Blood. 2011 Nov 24;118(22):5938-46
pubmed: 21926352
Laryngoscope. 2005 Jul;115(7):1154-62
pubmed: 15995500
Immunopharmacol Immunotoxicol. 1994 Aug;16(3):319-46
pubmed: 7528237
Biomed Pharmacother. 2018 Feb;98:523-530
pubmed: 29287200
Chimerism. 2015 Apr 3;6(1-2):40-5
pubmed: 27171577
Science. 1988 Sep 23;241(4873):1632-9
pubmed: 2971269
Cancer Res. 2003 Apr 1;63(7):1615-22
pubmed: 12670913
Diabetes. 2005 May;54(5):1423-8
pubmed: 15855329
J Immunol Res Ther. 2016;1(1):15-21
pubmed: 27774523
Radiat Oncol Investig. 1999;7(1):22-9
pubmed: 10030620
Mol Cell Biol. 2001 Mar;21(5):1444-52
pubmed: 11238881
Oncotarget. 2016 Oct 11;7(41):66635-66646
pubmed: 27556180
Br J Pharmacol. 2016 Feb;173(4):635-48
pubmed: 26013585
Clin Otolaryngol. 2018 Feb;43(1):13-21
pubmed: 28464441
Eur J Cell Biol. 1984 Sep;35(1):35-40
pubmed: 6489358
Oncogene. 1997 Mar 13;14(10):1185-90
pubmed: 9121767
J Immunol. 2008 May 15;180(10):7009-18
pubmed: 18453623
Cell. 1992 Mar 6;68(5):855-67
pubmed: 1547487
Toxicol Appl Pharmacol. 2012 Jul 15;262(2):107-16
pubmed: 22561872
Cancer Res. 2004 Aug 1;64(15):5054-8
pubmed: 15289303
Int J Cancer. 2000 May 1;86(3):368-74
pubmed: 10760825
Otolaryngol Head Neck Surg. 2012 Sep;147(3):493-500
pubmed: 22434099
Exp Cell Res. 2017 Nov 15;360(2):105-112
pubmed: 28843961
Laryngoscope. 1985 Jan;95(1):43-56
pubmed: 3855324
Lab Anim Res. 2017 Jun;33(2):119-123
pubmed: 28747977
Immunity. 1995 Mar;2(3):223-38
pubmed: 7697543
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
BMC Immunol. 2016 Jun 16;17(1):18
pubmed: 27307066
Front Oncol. 2015 Jul 08;5:128
pubmed: 26217583
J Dent Res. 2018 Jul;97(7):742-750
pubmed: 29443582
Ann N Y Acad Sci. 2005 Jun;1044:236-43
pubmed: 15958717
J Oral Pathol. 1983 Oct;12(5):375-84
pubmed: 6415258
Oncotarget. 2015 Dec 22;6(41):43408-19
pubmed: 26485767
Int Arch Allergy Appl Immunol. 1980;62(3):330-3
pubmed: 6993372
Int J Cancer. 1999 Jul 30;82(3):377-84
pubmed: 10399955
Blood. 2006 Jul 15;108(2):487-92
pubmed: 16410443
Oral Oncol. 2008 Nov;44(11):1080-7
pubmed: 18396447
Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1056-H1066
pubmed: 18599597
Med Sci Monit Basic Res. 2015 Oct 20;21:235-40
pubmed: 26482575
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):301-13
pubmed: 14734483
Oncotarget. 2015 Nov 3;6(34):36400-17
pubmed: 26506415
Head Neck. 2010 Feb;32(2):184-90
pubmed: 19626638
Br J Cancer. 1982 Jul;46(1):109-16
pubmed: 7201845
Br J Exp Pathol. 1988 Oct;69(5):749-58
pubmed: 2461729
J Immunol. 2017 Dec 1;199(11):3849-3857
pubmed: 29070673
Mutat Res. 2008 Jul-Aug;659(1-2):15-30
pubmed: 18485806
PLoS One. 2015 Feb 17;10(2):e0116799
pubmed: 25689279
J Exp Clin Cancer Res. 2017 Sep 2;36(1):116
pubmed: 28865486
J Exp Med. 2009 Jan 16;206(1):25-34
pubmed: 19103877
Cancer Lett. 2012 Apr 28;317(2):199-206
pubmed: 22123294
Annu Rev Immunol. 2013;31:635-674
pubmed: 23330956
Oncotarget. 2016 Apr 12;7(15):20840-54
pubmed: 26956044
Mol Cell Biochem. 2018 Nov;448(1-2):145-153
pubmed: 29435870
Blood. 2010 Nov 18;116(20):4158-67
pubmed: 20671122
J Dent Res. 1999 Jun;78(6):1264-9
pubmed: 10371251
Head Neck Oncol. 2009 Aug 13;1:32
pubmed: 19678942
Clin Cancer Res. 2017 Feb 1;23(3):833-844
pubmed: 27492974
Vet J. 2016 Apr;210:7-16
pubmed: 26965084
Nature. 1968 Jan 27;217(5126):370-1
pubmed: 5639157
Int J Cancer. 2016 Sep 15;139(6):1379-90
pubmed: 27164411
Nature. 1983 Feb 10;301(5900):527-30
pubmed: 6823332
Stem Cell Reports. 2017 Oct 10;9(4):1034-1042
pubmed: 28966117
Oncogene. 2012 Jul 12;31(28):3322-32
pubmed: 22037217
Carcinogenesis. 1986 May;7(5):783-8
pubmed: 3084119
J Transl Med. 2013 Aug 27;11:198
pubmed: 23981300
Vet Pathol. 2006 Jul;43(4):401-23
pubmed: 16846982
Science. 1995 Feb 24;267(5201):1178-83
pubmed: 7855601
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
Nature. 1988 Sep 15;335(6187):256-9
pubmed: 2970594
Oral Oncol. 2017 Feb;65:51-56
pubmed: 28109468
Cytokine Growth Factor Rev. 2010 Oct;21(5):365-79
pubmed: 20870448
J Reprod Immunol. 2005 Dec;68(1-2):39-51
pubmed: 16309747
Genet Res. 1966 Dec;8(3):295-309
pubmed: 5980117
Dan Med Bull. 1990 Oct;37(5):433-42
pubmed: 2125549
Mol Carcinog. 2018 Mar;57(3):429-439
pubmed: 29215754
Science. 1988 Dec 23;242(4886):1706-9
pubmed: 2904703
Carcinogenesis. 2011 Oct;32(10):1441-9
pubmed: 21771729
J Immunol. 2017 Aug 15;199(4):1505-1515
pubmed: 28696255
J Osaka Dent Univ. 1996 Dec;30(1-2):29-35
pubmed: 9485768
J Oral Pathol Med. 2003 Oct;32(9):530-7
pubmed: 12969227
FASEB J. 2018 Mar;32(3):1537-1549
pubmed: 29146734
Mol Cancer. 2017 Jun 7;16(1):99
pubmed: 28592285
Immunology. 2018 May;154(1):50-61
pubmed: 29446074
Front Immunol. 2018 Feb 02;9:152
pubmed: 29456539
World J Gastrointest Oncol. 2015 Dec 15;7(12):455-65
pubmed: 26690981
Cancer Res. 2009 Feb 1;69(3):948-57
pubmed: 19176392